AUS
NZ
UK
CA
USA
IND
Healthcare
Telix's New Healthcare Collaboration Sparks Fresh Market Discussion
June 16, 2026 10:43 AM AEST| By SamTelix Pharmaceuticals strengthened its precision medicine strategy through a new healthcare collaboration that combines imaging technologies, artificial intelligence tools, and theranostic workflows.
Healthcare Stocks Back in Focus as Device and Diagnostics Trends Gain Attention
June 15, 2026 08:46 PM AEST| By SamHealthcare stocks are gaining attention as device and diagnostics activity supports sector momentum, with investors tracking demand trends, cash flow strength, and broader market signals across major ASX healthcare names.
Healthcare Stocks Back In Focus As Market Searches For Stability
June 15, 2026 08:43 PM AEST| By SamHealthcare stocks are gaining renewed attention as market participants evaluate earnings strength, global demand and sector leadership across major healthcare companies listed on the Australian market.
Why Are Investors Monitoring Magellan Financial Group (ASX:MFG) Stock?
June 15, 2026 06:54 PM AEST| By Sonal GoyalMagellan Financial Group Limited (ASX:MFG) posted a modest gain during trading on 15 June 2026, with shares rising 0.32% to AUD 9.55. The increase represented a gain of AUD 0.03 from the previous closing price of AUD 9.52.
Telix Pharmaceuticals ASX TLX 2026: Radiopharma Growth Surge
June 15, 2026 02:19 PM AEST| By SamTelix Pharmaceuticals (ASX:TLX) is expanding rapidly in radiopharmaceuticals, supported by FDA progress, a major Regeneron partnership and strong revenue growth within the ASX healthcare sector.
CSL Under Pressure: Can the Healthcare Giant Rebuild Momentum?
June 15, 2026 02:14 PM AEST| By SamCSL is navigating a complex restructuring phase after a challenging year, with early signs of stabilisation emerging as the company refocuses on plasma, vaccines and long-term innovation.
RMD Shares on Watch as Healthcare Trends Shift in 2026
June 15, 2026 10:22 AM AEST| By SamResMed continues to attract market attention as healthcare trends evolve, with global demand, digital health growth and valuation debates shaping sentiment across the ASX healthcare sector in 2026.
Is Your SMSF Ready for Division 296? Key Tax Risks for Large Super Balances
June 15, 2026 01:56 PM AEST| By Aditi SarkarSelf-managed superannuation funds give trustees direct control over how their retirement savings are invested, and that control often comes with concentrated or illiquid assets. Those same features make SMSFs a focal point in discussions about Division 296, the proposed $3 million super tax. For …
ASX 200 Health Stocks Turnaround: Why CSL and RMD Are Rising Again
June 14, 2026 05:09 PM AEST| By SamASX healthcare stocks including CSL, Cochlear and ResMed are rebounding after extended weakness, supported by valuation resets, sector rotation and stabilising sentiment across medical and pharmaceutical industries.
CSL Outlook Shift After Impairments Raises Fresh Debate
June 14, 2026 03:55 PM AEST| By SamCSL has revised its earnings outlook following impairments and global market shifts, with US distribution changes and China pricing pressures shaping performance expectations ahead of upcoming financial reporting periods.
ASX 200 Rallies Into Week’s End as CSL Surges and Uranium Stocks Slide
June 14, 2026 10:56 AM AEST| By SamThe ASX 200 posted strong weekly gains led by CSL and consumer stocks, while uranium and growth shares declined amid sector rotation and shifting macro expectations.
SMSF Investors on Alert: What Division 296 Means for Wealth Preservation
June 15, 2026 01:56 PM AEST| By Aditi SarkarSelf-managed superannuation funds have long appealed to investors who want control: control over assets, over timing, and over how wealth eventually passes to the next generation. Many SMSF trustees have used that control to build substantial balances, often anchored by direct property, private investments …
Monash IVF Group ASX 300 Updates Earnings Outlook as Sector Activity Softens
June 12, 2026 11:07 AM AEST| By SamMonash IVF Group updated its earnings outlook amid softer fertility sector activity while expanding market share, strengthening international operations and continuing clinical network development initiatives.
Why OncoSil’s Quiet Update Could Signal a Defining Period Ahead
June 12, 2026 11:05 AM AEST| By SamOncoSil enters a crucial phase as regulatory progress, clinical data, manufacturing expansion, and commercial adoption become the central themes shaping its future.
Why ASX Healthcare Stocks Are Back Under the Microscope
June 11, 2026 09:46 PM AEST| By SamHealthcare stocks are being reassessed through the diagnostics and devices theme, with readers focusing on business quality, product adoption, operational discipline and the signals influencing sector sentiment.
Super Balances Over $3 Million? Division 296 Could Change Your Retirement Strategy
June 15, 2026 01:56 PM AEST| By Aditi SarkarThis piece focuses squarely on what the proposal could mean for contribution habits and the sequencing of withdrawals. It is written for general understanding, not as a prescription, because the final shape of the law and each person's circumstances will ultimately drive any sensible …
Healthcare Stocks Nobody Can Ignore as Valuation Repair Gains Pace
June 11, 2026 09:45 PM AEST| By SamHealthcare stocks are being reassessed through valuation repair, with markets focusing on revenue quality, product adoption, margins and execution as companies work to strengthen confidence across the Australian healthcare sector.
From Trial Hope to Revenue Proof: Why Healthcare Stocks Face a Bigger Test
June 11, 2026 09:43 PM AEST| By SamAustralian healthcare stocks are entering a more evidence-driven phase, with attention shifting towards commercial proof, revenue quality, product adoption and operational execution across leading healthcare businesses.
Why Are These Healthcare Stocks Capturing Market Attention?
June 11, 2026 03:00 PM AEST| By SamSeven healthcare companies spanning biotechnology, diagnostics, hospitals, medical devices, and healthcare software continue drawing attention across Australia's healthcare sector and major market indices.
Super Tax Changes: Why Professional Advice Matters More Under Division 296
June 15, 2026 01:56 PM AEST| By Aditi SarkarNothing here is a recommendation about what any individual should do. The point is more general: complex, evolving policy is exactly the setting in which qualified guidance earns its place, because the right course depends on facts that differ from person to person.
Which Healthcare Leader Commands More Attention Now?
June 11, 2026 03:00 PM AEST| By SamLeading ASX healthcare companies continue to attract attention through biotechnology, diagnostics, hearing technology and respiratory care, supported by healthcare demand and operational quality.
Bell Potter Backs Cogstate as Healthcare Tech Growth Gains Momentum
June 11, 2026 02:22 PM AEST| By SamCogstate continues building momentum through healthcare technology innovation, strategic partnerships and expanding opportunities across clinical research markets.
Are ASX Healthcare Stocks Rebuilding Strength?
June 11, 2026 02:22 PM AEST| By SamASX healthcare stocks are being reviewed through operational resets, product adoption, hospital activity, diagnostics demand and medical software signals.
Division 296 for SMSFs: Tax Thresholds, Risks and Planning Options Explained
June 15, 2026 01:55 PM AEST| By Aditi SarkarSelf-managed superannuation funds sit at the centre of discussion about Division 296, the proposed additional 15% tax on the earnings attributable to balances above $3 million. SMSFs are popular among people with larger balances and often hold assets that are not traded on daily …
Canberra Drone Maker’s ASX Arrival Sparks Fresh Defence Focus
June 11, 2026 09:29 AM AEST| By SamBoresight has entered the ASX as a defence technology company specialising in aerial target drones, with global military customers, expanding manufacturing operations, and a growing role in modern defence training solutions.
ASX Healthcare Innovators 2026: Australia's Global Champions
June 10, 2026 09:55 PM AEST| By SamAustralia's healthcare sector has produced globally recognised leaders through innovation, specialised expertise and international expansion, with CSL, Cochlear, ResMed and Pro Medicus showcasing the country's ability to compete successfully on the w...
Advertise your brand on Kalkine Media